DXCM Q3 2020 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$26B

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$501M+26.4% YoY

Gross Profit

$340M68.0% margin

Operating Income

$94M18.8% margin

Net Income

$72M14.4% margin

EPS (Diluted)

$0.18

QoQ Revenue Growth

+10.9%

Cash Flow

Operating Cash Flow

$148M

Free Cash Flow

$100M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$3.8B

Total Liabilities

$2.3B

Stockholders' Equity

$1.5B

Cash & Equivalents

$674M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$501M	$396M	+26.4%
Gross Profit	$340M	$247M	+37.9%
Operating Income	$94M	$56M	+68.0%
Net Income	$72M	$46M	+57.6%

Geographic Segments

UNITED STATES

$399M80%

Non-US

$102M20%